{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:07:18Z","timestamp":1761487638185},"reference-count":0,"publisher":"Informa Healthcare","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Drug Discovery"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1517\/17460441.1.2.99","type":"journal-article","created":{"date-parts":[[2006,7,10]],"date-time":"2006-07-10T18:07:57Z","timestamp":1152554877000},"page":"99-102","source":"Crossref","is-referenced-by-count":34,"title":["Why has R&D productivity declined in the pharmaceutical industry?"],"prefix":"10.1517","volume":"1","author":[{"given":"Robert R","family":"Ruffolo","sequence":"first","affiliation":[]}],"member":"3197","published-online":{"date-parts":[[2006,7,10]]},"container-title":["Expert Opinion on Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/17460441.1.2.99","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T13:28:44Z","timestamp":1481635724000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/17460441.1.2.99"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":0,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2006,7,10]]},"published-print":{"date-parts":[[2006,7]]}},"alternative-id":["10.1517\/17460441.1.2.99"],"URL":"https:\/\/doi.org\/10.1517\/17460441.1.2.99","relation":{},"ISSN":["1746-0441","1746-045X"],"issn-type":[{"value":"1746-0441","type":"print"},{"value":"1746-045X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}